The NIH's Jay Bhattacharya argues that public distrust led to the cancellation of mRNA vaccine contracts. This statement contrasts with Health Secretary Kennedy's claims about vaccine safety and efficacy.
Health Secretary Robert F. Kennedy Jr.'s drastic funding cuts to mRNA vaccine research could stymie medical breakthroughs and push scientific talent away from the U.S., experts warn.
Former Surgeon General Dr. Jerome Adams warns that the U.S. risks lives by cutting funding for mRNA vaccine research, following Secretary Kennedy's controversial decision to halt key projects.
Discover how researchers at IBM and Moderna have leveraged quantum computing to predict the complex protein structure of mRNA, marking a significant advancement in vaccine technology.
In a surprising move, U.S. health officials have canceled $500 million in mRNA vaccine research, citing studies that question their safety and effectiveness. Critics warn this decision undermines vital public health advancements made during the pandemic.
In a bold move, Health Secretary Robert F. Kennedy Jr. announces eight new members to the CDC's vaccine advisory committee, some of whom have previously criticized vaccines, raising eyebrows and concerns about future recommendations.
In a controversial move, Health Secretary Robert F. Kennedy Jr. has replaced all members of the CDC's vaccine advisory panel with eight new appointees, raising concerns among public health advocates about potential anti-vaccine bias.
Robert F. Kennedy Jr. canceled a critical $766 million contract with Moderna for a bird flu vaccine, raising concerns about public health and vaccine safety amidst a potential outbreak.
In a surprising move, the HHS has terminated a $590 million contract with Moderna for H5 avian influenza vaccine development, raising alarms among health experts amidst rising H5N1 threats.
In a surprising move, the Department of Health and Human Services has withdrawn millions in funding for Moderna's bird flu vaccine development, raising concerns about the nation's pandemic preparedness amid ongoing tensions over vaccine safety.
